Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation

2 years ago

STOUGHTON, Mass., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being…

Baudax Bio Announces $4.2 Million Registered Direct Offering

2 years ago

MALVERN, Pa., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on commercializing…

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

2 years ago

DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing,…

Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS

2 years ago

HAMILTON, Bermuda, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio…

Correction: Regarding results of a share buy-back offer

2 years ago

Joint stock company “Olainfarm”, hereinafter referred to as - “the Company”, hereby informs that on the 27th of December, 2021 joint…

Nexstim Receives an NBS System Upgrade Order from a Customer in the United States

2 years ago

Press release, Helsinki, 28 December 2021 at 10 AM (EET) Nexstim Receives an NBS System Upgrade Order from a Customer…

On substantial participation (4) – specified

2 years ago

On December 27th, 2021 JSC Olainfarm has received specified announcement on substantial participation from AS AB CITY.  The received announcement…

Sosei Heptares to present at 40th Annual J.P. Morgan Healthcare Conference

2 years ago

TOKYO, Japan and LONDON, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565), today announced its…

Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate

2 years ago

First subject dosed with Nykode Therapeutics’ T cell focused SARS-CoV-2 vaccine candidate. This is part of the ongoing phase 1/2…

Burning Rock Announces Results of 2021 Annual General Meeting

2 years ago

GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a…